The money slide seems to be this which I have included below. Would be interested to hear opinions on this.
This strikes me as an unclear result and possibly a tad disappointing. I feel like a blood test to predict CKD progression would need to slightly higher sensitivity at this optimal cutoff than the ones presented in the CREDENCE analysis. If it had replicated the FDS2 study at 86% I feel like it would have been seen as a more positive result as it would have confirmed the potential of Promarker D.
But very interested in further thoughts and good luck to all holders.
PIQ Price at posting:
56.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)